MYD88 and aneurysmal bone cyst: Among them, the C5 group (64 cases) paralleled the previously described MCD group, being characterized by ABC DLBCLs with MYD88 (50%) and/or CD79B (48%) mutations and frequent 18q/BCL2 amplifications [17].